Top Clinical Trials companies in Hong Kong by Free Cash Flow Per Share
Hong Kong
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 0.22
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
| 2 |
USD 0.01
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
| 3 |
USD -0.01
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
| 4 |
USD -0.03
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
| 5 |
USD -0.31
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
|
| 6 |
USD -0.95
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
|
| 7 |
USD -1.31
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
Frequently Asked Questions
-
Which Clinical Trials company in Hong Kong has the highest Free Cash Flow Per Share ?
The Clinical Trials company in Hong Kong with the highest Free Cash Flow Per Share is HUTCHMED (China) Limited (HKSE: 0013.HK) at USD 0.22.
-
Which Clinical Trials company in Hong Kong has the lowest Free Cash Flow Per Share ?
The Clinical Trials company in Hong Kong with the lowest Free Cash Flow Per Share is Prenetics Global Limited (NasdaqGM: PRE) at USD -1.31.
-
What are the top 10 Clinical Trials companies in Hong Kong by Free Cash Flow Per Share ?
The top 10 Clinical Trials companies in Hong Kong by Free Cash Flow Per Share are HUTCHMED (China) Limited, Frontage Holdings Corporation, Lee's Pharmaceutical Holdings Limited, SinoMab BioScience Limited, Regencell Bioscience Holdings Limited, Sirnaomics Ltd. and Prenetics Global Limited.
-
What are the bottom 10 Clinical Trials companies in Hong Kong by Free Cash Flow Per Share ?
The bottom 10 Clinical Trials companies in Hong Kong by Free Cash Flow Per Share are Prenetics Global Limited, Sirnaomics Ltd., Regencell Bioscience Holdings Limited, SinoMab BioScience Limited, Lee's Pharmaceutical Holdings Limited, Frontage Holdings Corporation and HUTCHMED (China) Limited.
